Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell-based therapy for liver diseases.

C Di Campli1, M Nestola, A C Piscaglia

  • 1Istituto di Medicina Interna e Geriatria, Università Cattolica del Sacro Cuore, Policlinico Gemelli - Roma, Italy.

European Review for Medical and Pharmacological Sciences
|August 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strongyloides stercoralis infection in San Marino Republic: first epidemiological data from an observational study.

Epidemiology and infection·2019
Same author

Medicine in the time of Carracci: the cases of Domenico Lanzoni and Giuseppe Rosaccio.

European review for medical and pharmacological sciences·2019
Same author

Microbes and Alzheimer' disease: lessons from H. pylori and GUT microbiota.

European review for medical and pharmacological sciences·2019
Same author

Polymethylmethacrylate-augmented fenestreted pedicle-screw fixation in low bone quality patients: a case series and literature review.

Journal of biological regulators and homeostatic agents·2019
Same author

On the shoulders of giants: a history of success and a future of excellence - Istituto Ortopedico Rizzoli.

European review for medical and pharmacological sciences·2018
Same author

Gut microbiota and aging.

European review for medical and pharmacological sciences·2018
Same journal

Retraction Note: Can the endometrioma be an obstacle to complete oocyte retrieval in IVF cycles? A retrospective study.

European review for medical and pharmacological sciences·2026
Same journal

Retraction Note: A multicenter clinical study with myo-inositol and alpha-lactalbumin in Mexican and Italian PCOS patients.

European review for medical and pharmacological sciences·2026
Same journal

Retraction Note: Oxycodone inhibits myocardial cell apoptosis after myocardial ischemia-reperfusion injury in rats via RhoA/ROCK1 signaling pathway.

European review for medical and pharmacological sciences·2026
Same journal

Intracoronary stem cell transplant in ischemic heart disease: a meta-analysis of randomized trials.

European review for medical and pharmacological sciences·2026
Same journal

From models to medicine: advanced preclinical systems and AI enabling RNA therapeutics in triple-negative breast cancer.

European review for medical and pharmacological sciences·2026
Same journal

Association of serum asprosin levels with obesity indices and metabolic parameters in adults.

European review for medical and pharmacological sciences·2026
See all related articles

Liver transplantation is standard for liver failure, but cell-based therapies offer alternatives. Research explores various cell sources for liver repopulation and bioartificial devices for future treatments.

Area of Science:

  • Hepatology
  • Regenerative Medicine
  • Bioengineering

Background:

  • Liver transplantation is a standard treatment for liver failure.
  • Challenges exist in managing liver failure patients post-transplantation.
  • Cellular therapies are emerging as promising alternatives.

Purpose of the Study:

  • To explore alternative cell sources for liver repopulation.
  • To investigate the potential of hepatocytes in bioartificial devices.
  • To discuss future directions in cell-based liver disease treatment.

Main Methods:

  • Review of current research on isolated hepatocytes and bioartificial devices.
  • Investigation into alternative cell sources: xenogenic cells, hepatoma cells, immortalized hepatocytes, and stem cells.

Related Experiment Videos

  • Analysis of advancements in liver cell biology and artificial device development.

    • Main Results:

    • Isolated hepatocytes can replace synthetic and metabolic liver functions.
    • Genetically modified hepatocytes offer potential for treating genetic liver diseases.
    • Various alternative cell sources are under investigation, but no gold standard exists.

    Conclusions:

    • Cell-based procedures, including isolated hepatocytes and bioartificial devices, are promising for liver failure.
    • Future therapeutic approaches will likely integrate advancements in artificial devices and liver cell biology.
    • Personalized cell-based treatments may be tailored to specific clinical situations.